Lanean...

Exploiting viral natural history for vaccine development

The partial successes of the Phase 2 gB-based vaccine trials for HCMV highlight the very real likelihood that vaccine-mediated induction of antibodies that neutralize the fusion pathway of fibroblast infection is not sufficient as a singular strategy to confer protective efficacy against primary HCM...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Med Microbiol Immunol
Egile nagusia: Barry, Peter A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2015
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4439440/
https://ncbi.nlm.nih.gov/pubmed/25794555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00430-015-0406-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!